Analyst Coverage

Stifel Nicolaus Europe Limited

James Mainwaring
Phone: +44(0)20 7710 7495

Max Herrmann
Phone: +44 (0) 20 7710 7606

150 Cheapside
London EC2V 6ET
United Kingdom

06 July 2018 Initiation Report 4SC AG (VSC – XETRA; VSCk.DE)

LifeSci Capital LLC

Sam Slutsky
250 West 55th Street, 34th Floor
New York, NY 10019

Phone: +1 212 915 2573

8 August 2019 Company Update 4SC AG (VSC.F): Q2 2019 Corporate and Financial Update; Several Near Term Milestones
18 April 2019 Company Update 4SC AG (VSC.F): 4SC Provided Q1 2019 Update; Main Near-Term Focus on Efficacy Data from SENSITIZE Trial
3 April 2019 Conference Update AACR 2019: Covered Company Presentations #1
20 March 2019 Company Update 4SC AG (VSC.F): 4SC Reports Full Year 2018 Financial Results and Provides Corporate Update
09 August 2018 Company Update 4SC AG (VSC.F): 4SC Reported Q2 and H1 2018 Financials and Provided Timelines for its Clinical Studies
03 July 2018 Company Update 4SC AG (VSC.F): SRC Recommends Phase Ib/II Study with Domatinosat Continue; Results from Multiple Cohorts Coming in H2 2018
29 June 2018 Initiation Report 4SC AG (VSC.F)


Any opinions, estimates or forecasts made by these analysts on the performance of 4SC AG are not opinions, forecasts or predictions of 4SC AG or its management. By providing the list above, 4SC AG does not imply its endorsement of or concurrence with such information, conclusions or recommendations.

The list has been drawn up to the best of our knowledge. 4SC AG cannot give any assurance that the list represents a full overview of all analyst reports available on the market. This list may not be complete and may change from time to time. We update the list periodically, but undertake no obligation to do so.

Share this page:

Follow us on: